Physician profile
Harry V Phillips, III
NPI 1588651954
$2,027.69
in general payments reported to CMS, 2019-2025
22 companies · $366 in 2025
The $366 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $112 · 2021: $273 · 2022: $354 · 2023: $255 · 2024: $267 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $299.62 | 2019-2025 | Bexsero, Penmenvy, Pediarix |
| Ironshore Pharmaceuticals INC. | $262.33 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $233.35 | 2019-2025 | Gardasil 9, Rotateq, Vaxneuvance |
| Pfizer INC. | $191.66 | 2019-2025 | |
| Sanofi Pasteur INC. | $160.51 | 2022-2025 | |
| Tris Pharma INC | $146.73 | 2020-2022 | |
| Supernus Pharmaceuticals, INC. | $134.06 | 2021-2023 | Qelbree |
| Kaleo, INC. | $87.66 | 2019-2022 | |
| Seqirus USA INC | $77.36 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Collegium Pharmaceutical, INC. | $70.89 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $61.40 | 2019-2021 | |
| Cranial Technologies, INC | $55.68 | 2025 | Doc Band |
| Neos Therapeutics, LP | $49.09 | 2019 | |
| Corium, LLC | $46.56 | 2025 | Azstarys |
| Novo Nordisk INC | $34.06 | 2023-2024 | Wegovy, Saxenda |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $32.33 | 2019-2021 | |
| Aimmune Therapeutics, INC. | $15.27 | 2021 | |
| Genentech USA, INC. | $15.22 | 2019 | |
| Mission Pharmacal Company | $15.17 | 2019 | |
| Sobi, INC | $13.93 | 2019 | |
| Hologic Sales and Service, LLC | $12.81 | 2020 | |
| Shire North American Group INC | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.